02196 FOSUN PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.93X | Oper Margin | 10.7% |
|---|---|---|---|
| LT Debt/Equity | 30.6% | Net Margin | 8.1% |
| Total Debt/Equity | 74.6% | Return on Equity | 6.9% |
| Price/Book | 1.01X | Return on Assets | 2.8% |
| (HKD 20.800) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 3,751.77 | 2,945.77 | 2,643.74 | 4,189.90 | 5,783.69 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +27.4 | +11.4 | -36.9 | -27.6 | +33.1 |
| Earnings Per Share (HKD) | 1.418 | 1.103 | 0.99 | 1.607 | 2.257 |
| Earnings Per Share Growth (%) | +28.5 | +11.4 | -38.4 | -28.8 | +33.1 |
| Dividend Per Share (HKD) | 0.434 | 0.350 | 0.300 | 0.460 | 0.660 |
| P/E* (X) | 14.67 | 18.86 | 21.00 | 12.94 | 9.22 |
| Yield (%) | 2.09 | 1.68 | 1.44 | 2.21 | 3.17 |
| Dividend Share (%) | 30.62 | 31.73 | 30.29 | 28.63 | 29.25 |
| Book NAV (HKD) | 20.538 | 18.894 | 18.826 | 18.685 | 18.678 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 41,498 | 40,910 | +1.4 | 41,249 |
| Operating Result | 2,119 | 1,574 | +34.6 | 375.896 |
| Associates | 1,924 | 1,644 | +17.0 | 2,185 |
| Profit Before Taxation | 5,112 | 4,169 | +22.6 | 3,277 |
| Taxation | 864.054 | 656.841 | +31.5 | 369.504 |
| Profit /( Loss) After Taxation | 4,248 | 3,512 | +21.0 | 2,907 |
| Minority Interests | 877.368 | 742.554 | +18.2 | 508.798 |
| Net Profit | 3,371 | 2,770 | +21.7 | 2,399 |
| Earnings Per Share () | 1.4177 | 1.1031 | +28.5 | 0.9903 |
| Dividend Per Share () | 0.4341 | 0.3500 | +24.0 | 0.3000 |
| Announcement Date | 2026-03-25 | 2025-03-25 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
